Tomokatsu Hongo

Corporate Officer

Tomokatsu Hongo

Corporate Officer

Tomokatsu Hongo

Hongo graduated from the Graduate School of Engineering at Nagoya University, obtaining a PhD in biochemical engineering.
He worked at Summit Pharmaceuticals International Corporation overseeing VC funds, investments in bio-ventures, and managing domestic sales for overseas bio-ventures in Japan.
In 2016, Hongo joined KII as a corporate officer as well as a lead investor specializing in the medical healthcare field. Utilizing his business experience and career as a researcher in the pharmaceutical industry, he oversees investments in startups dealing with drug discovery and regenerative medicine, and investments in and support for the activities of medical device startups.

Activity

Portfolio